Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04233697
Title Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Changchun Deng
Indications

Hodgkin's lymphoma

mature T-cell and NK-cell lymphoma

non-Hodgkin lymphoma

Therapies

Copanlisib + Romidepsin

Age Groups: senior | adult
Covered Countries


No variant requirements are available.